236 related articles for article (PubMed ID: 26537419)
21. Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol.
Yuan H; Huang Z; Yang G; Lv H; Sang H; Yao Y
J Int Med Res; 2008; 36(6):1354-62. PubMed ID: 19094446
[TBL] [Abstract][Full Text] [Related]
22. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
23. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
Bauman JL; Talbert RL
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
[TBL] [Abstract][Full Text] [Related]
25. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
Ozbilen S; Eren MA; Turan MN; Sabuncu T
Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
[TBL] [Abstract][Full Text] [Related]
26. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
[TBL] [Abstract][Full Text] [Related]
27. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
28. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
[TBL] [Abstract][Full Text] [Related]
30. An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
Batty JA; Hall AS; White HL; Wikstrand J; de Boer RA; van Veldhuisen DJ; van der Harst P; Waagstein F; Hjalmarson Å; Kjekshus J; Balmforth AJ;
Clin Pharmacol Ther; 2014 Mar; 95(3):321-30. PubMed ID: 24193112
[TBL] [Abstract][Full Text] [Related]
31. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
[TBL] [Abstract][Full Text] [Related]
32. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
Doggrell SA
Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
[TBL] [Abstract][Full Text] [Related]
33. Comparison of metoprolol succinate versus carvedilol in time to cardiovascular admission in a Veterans Affairs healthcare system: An observational study.
Church KM; Henalt R; Baker E; Smith GL; Brennan MT; Joseph J
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S183-90. PubMed ID: 26582307
[TBL] [Abstract][Full Text] [Related]
34. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
[TBL] [Abstract][Full Text] [Related]
35. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
36. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.
Giessmann T; Modess C; Hecker U; Zschiesche M; Dazert P; Kunert-Keil C; Warzok R; Engel G; Weitschies W; Cascorbi I; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2004 Mar; 75(3):213-22. PubMed ID: 15001973
[TBL] [Abstract][Full Text] [Related]
37. Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity.
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S217-21. PubMed ID: 15683500
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
[TBL] [Abstract][Full Text] [Related]
39. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
40. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]